Your browser doesn't support javascript.
loading
The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma.
Forker, Laura; Gaunt, Piers; Sioletic, Stefano; Shenjere, Patrick; Potter, Robert; Roberts, Darren; Irlam, Joely; Valentine, Helen; Hughes, David; Hughes, Ana; Billingham, Lucinda; Grimer, Rob; Seddon, Beatrice; Choudhury, Ananya; Robinson, Martin; West, Catharine M L.
Afiliação
  • Forker L; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Gaunt P; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Sioletic S; Department of Pathology, Ospedale S.Camillo de Lellis, Rieti 02100, Italy.
  • Shenjere P; Department of Histopathology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Potter R; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Roberts D; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Irlam J; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Valentine H; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Hughes D; Department of Histopathology, Sheffield Teaching Hospitals NHS Trust, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK.
  • Hughes A; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Billingham L; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Grimer R; Department of Orthopaedic Oncology, Royal Orthopaedic Hospital NHS Foundation Trust, Bristol Road South, Northfield, Birmingham B31 2AP, UK.
  • Seddon B; Department of Oncology, University College London Hospitals NHS Foundation Trust, 1st Floor Central, 250 Euston Road, London NW1 2PG, UK.
  • Choudhury A; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • Robinson M; Department of Oncology, Academic Unit of Clinical Oncology (Cancer Clinical Trials Centre), Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK.
  • West CML; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
Br J Cancer ; 118(5): 698-704, 2018 03 06.
Article em En | MEDLINE | ID: mdl-29235571
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Biomarcadores Tumorais / Regulação para Cima / Anidrase Carbônica IX / Antígenos de Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Biomarcadores Tumorais / Regulação para Cima / Anidrase Carbônica IX / Antígenos de Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article